Predictors of mortality in invasive pneumococcal disease: a meta-analysis

Expert Rev Anti Infect Ther. 2021 Jul;19(7):927-944. doi: 10.1080/14787210.2021.1858799. Epub 2020 Dec 31.

Abstract

Objectives: To assess risk factors for mortality in invasive pneumococcal disease (IPD).

Methods: We conducted a systemic literature search in January 2019. The main outcome measure included death within 30 days after diagnosis of IPD. The study protocol was registered in PROSPERO (CRD42019120189).

Results: After reviewing 2514 potentially relevant records, remaining 190 articles were included in the analysis. A total of 228,782 IPD patients were identified and the mortality rate was 17.2% in the included articles. No significant evidence of publication bias was found according to the funnel plot and Egger's test (t = 1.464, p = 0.145). Male sex, older age, alcohol abuse, previous tuberculosis, meningitis, hospital acquired infections, multilobar infiltrate or effusion, Pitt bacteremia score≥4, Pneumonia Severity Index≥4, clinical conditions requiring intensive care, underlying clinical conditions, disease caused by serotypes 3, 6B, 9 N, 10A, 11A, 16 F, 17 F, 19, 19 F, 22 F, 23A, 23 F, 31 and 35 F, previous antibiotic use, inappropriate initial antibiotic therapy, penicillin resistance, and vancomycin use during the course of treatment were predicators of 30-day mortality.

Conclusions: This meta-analysis highlights important risk factors for IPD-related mortality, many of which may be targeted through preventive measures.

Keywords: Invasive pneumococcal disease; meta-analysis; mortality; pneumococcal infection; risk factors; streptococcus pneumoniae.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Age Factors
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / microbiology
  • Bacteremia / mortality
  • Drug Resistance, Bacterial
  • Humans
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / mortality*
  • Pneumonia, Pneumococcal / mortality
  • Risk Factors
  • Sex Factors

Substances

  • Anti-Bacterial Agents